Fenucure Medical ApS: Financial statements 2017
CVR: 28486871
Source: annual report 2017, Danish Business Authority
01/07/2016 – 30/06/2017
Fenucure Medical ApS (CVR 28486871) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -1,603,315 and a net result of DKK -2,164,303 compared with DKK -1,818,594 the year before. Equity in the 2017 report amounted to DKK 120,955. The solvency ratio was 3.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -1,603,315
- Profit/Loss
- DKK -2,164,303
- Equity
- DKK 120,955
- Total Assets
- DKK 3,119,766
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -1.6M | -2.2M | 121K | 1 |
| 2016 | 200K | -1.7M | -1.8M | -3.2M | - |
| 2015 | 1.2M | -723K | -1.1M | -1.3M | - |
| 2014 | - | -10K | -26K | -178K | - |
| 2013 | - | -13K | -152K | -152K | - |
Official annual report
Keep an eye on Fenucure Medical ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout Fenucure Medical ApS
Fenucure Medical ApS is a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2005. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named V-BIOTEK ApS and VIND INVEST ApS. The management consists of Christian Hother Sørensen. The board consists of Nicolai Fink Gundersen (chair), Alex Gundersen, Mogens Viktor Madsen and Niels Christian Beck Vase. The company is owned by V-BIOTEK HOLDING ApS, Redwood Foundation ApS and Alex Gundersen Assens ApS. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK -1,214,608 and a net result of DKK -3,201,378 compared with DKK -1,529,007 the year before. Equity in the 2025 report amounted to DKK 593,861.